Endocrinología
Teprotumumab for patients with active thyroid eye disease
Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials
Published:April 15, 2021
DOI: https://doi.org/10.1016/S2213-8587(21)00056-5
- Lee más sobre Teprotumumab for patients with active thyroid eye disease
- Inicie sesión para enviar comentarios
Early pulse glucocorticoid therapy and improved hormonal outcomes in primary hypophysitis
Neuroendocrinology 2021 Mar 19
Metastatic Pheochromocytomas and Abdominal Paragangliomas
The Journal of Clinical Endocrinology & Metabolism, Volume 106, Issue 5, May 2021, Pages e1937–e1952,
https://doi.org/10.1210/clinem/dgaa982
- Lee más sobre Metastatic Pheochromocytomas and Abdominal Paragangliomas
- Inicie sesión para enviar comentarios
Statins Decrease the Risk of Orbitopathy in Newly Diagnosed Patients with Graves Disease
The Journal of Clinical Endocrinology & Metabolism, Volume 106, Issue 5, May 2021, Pages 1325–1332, https://doi.org/10.1210/clinem/dgab070
Published: 09 February 2021
Abstract
Context/objective
The aim of this study was to examine the effect of statins and other lipid-lowering agents on the development of Graves orbitopathy (GO) in patients with newly diagnosed Graves disease (GD).
Methods
Clinical, Diagnostic, and Therapeutic Aspects of Growth Hormone Deficiency During the Transition Period: Review of the Literature
Matteo Spaziani, Chiara Tarantino, Natascia Tahani, Daniele Gianfrilli, Emilia Sbardella, Andrea M Isidori, Andrea Lenzi, Antonio F Radicioni
Frontiers in Endocrinology 2021, 12: 634288
Assessment of mild autonomous cortisol secretion among incidentally discovered adrenal masses
Best Pract Res Clin Endocrinol Metab. 2021 Feb 6;101491.
PMID: 33593680